Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription 30.06.2025 1 Am J Surg 1 Ann Oncol 1 Ann Surg Oncol 4 Ann Thorac Surg 6 Anticancer Res 1 Cancer 1 Cancer Epidemiol Biomarkers Prev 1 Cancer Lett 3 Chest 2 Clin Cancer Res 2 Clin Lung Cancer 1 Eur J Cancer 4 Int J Radiat Oncol Biol Phys 1 J Clin Oncol 1 J Thorac Cardiovasc Surg 2 JAMA Oncol 7 Lung Cancer 2 Mol Carcinog 3 Oncologist 2 PLoS One 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. WILLIAMS JE, Jacobson-Davies F, Jacobs RC, Chang AC, et al
   Association of social vulnerability on time-to-treatment for patients with non-small cell lung cancer.
   Am J Surg. 2025;247:116481.
   PubMed         Abstract available
   
   

   
   Ann Oncol

2. RICCIUTI B, Scalera S, Wang X, Elkrief A, et al
   DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small cell lung cancer.
   Ann Oncol. 2025 Jun 18:S0923-7534(25)00804-X. doi: 10.1016/j.annonc.2025.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. LI P, Huang K, Wu Q, Che G, et al
   Influence of Cycles of Neoadjuvant Chemoimmunotherapy on Treatment Response in Stage IIIA-N2IIIB Non-small Cell Lung Cancer: Experience from a Large-Volume Center.
   Ann Surg Oncol. 2025 Jun 24. doi: 10.1245/s10434-025-17598.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

4. HURR R, Potter AL, Jeffrey Yang CF
   Improving Lung Cancer Screening Uptake Takes a Village: The Power of Partnering with High Catchment Hospital Departments.
   Ann Thorac Surg. 2025 Jun 18:S0003-4975(25)00532.
   PubMed        
   
   
5. RYUKO T, Okazaki M, Mitsuhashi T, Suzawa K, et al
   Comparable Clinical Outcomes Between Segmentectomy and Lobectomy for NSCLC With Unsuspected N1/N2: A Multicenter Real-World Data Study.
   Ann Thorac Surg. 2025;120:87-98.
   PubMed         Abstract available
   
   
6. WEN J, Chen T, Li Y, Dong Y, et al
   Comparison of Short- and Long-term Outcomes in Patients Undergoing Sleeve Lobectomy With or Without Buttressing the Bronchial Anastomosis.
   Ann Thorac Surg. 2025;120:100-107.
   PubMed         Abstract available
   
   
7. OPITZ I, Lauk O, Werner R, Matter A, et al
   Characteristics of Long-term Survivors With Malignant Pleural Mesothelioma.
   Ann Thorac Surg. 2025;120:108-116.
   PubMed         Abstract available
   
   

   
   Anticancer Res

8. LI JM, Yang KT, Wu CP
   Physalin F Inhibits Cell Viability and Induces Apoptosis in Non-small Cell Lung Cancer Cells.
   Anticancer Res. 2025;45:3031-3044.
   PubMed         Abstract available
   
   
9. SOMBOONVORAVONG W, Petsri K, Racha S, Sriratanasak N, et al
   Artogomezianone Inhibits EGFR and Promotes Apoptosis in Non-small Cell Lung Cancer Cells.
   Anticancer Res. 2025;45:2833-2845.
   PubMed         Abstract available
   
   
10. AIDA R, Okano K, Nakata K, Hagiwara H, et al
    Apigenin-induced Apoptosis in Lung Adenocarcinoma A549 Cells: Involvement in IFNA2, TNF, and SPON2 With Different Time Points.
    Anticancer Res. 2025;45:2781-2790.
    PubMed         Abstract available
    
    
11. PHANSOM N, Ei ZZ, Innets B, Wattanathana W, et al
    Development of a Benzoxazine-derived Inhibitor Targeting Epithelial-to-Mesenchymal Transition in Lung Cancer.
    Anticancer Res. 2025;45:2807-2815.
    PubMed         Abstract available
    
    
12. KIM HL, Park J, Kim HI, Boo M, et al
    Integrating Network Pharmacology and Optimization of Preparation Methods to Enhance the Anticancer Effect of Cordyceps militaris on Lung Cancer.
    Anticancer Res. 2025;45:2963-2984.
    PubMed         Abstract available
    
    
13. INNETS B, Racha S, Ei ZZ, Sriratanasak N, et al
    Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer.
    Anticancer Res. 2025;45:3021-3029.
    PubMed         Abstract available
    
    

    
    Cancer

14. BROWN LM, Wilkins SG, Bansal VV, Su DG, et al
    Consensus guideline for the management of peritoneal mesothelioma.
    Cancer. 2025;131:e35868.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

15. BERKMAN AM, Tran M, Thompson LK, Lerman C, et al
    SECONDARY LUNG CANCER AMONG SURVIVORS OF ADOLESCENT AND YOUNG ADULT CANCER: A POPULATION-BASED STUDY.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed         Abstract available
    
    

    
    Cancer Lett

16. HUANG Y, Song J, Chen J, Li F, et al
    The significance of protein N-glycosylation in the pathogenesis of lung cancer and its clinical implications.
    Cancer Lett. 2025 Jun 25:217849. doi: 10.1016/j.canlet.2025.217849.
    PubMed         Abstract available
    
    

    
    Chest

17. XIE Y, Zhang Y, Zhang P, Li Y, et al
    Timing of screening benefit for lung cancer with low-dose computed tomography.
    Chest. 2025 Jun 18:S0012-3692(25)00707-X. doi: 10.1016/j.chest.2025.
    PubMed         Abstract available
    
    
18. BARTA JA, Arenberg D, Backhus L, Detterbeck F, et al
    Components Necessary for High-Quality Lung Cancer Screening: A 10-Year Update.
    Chest. 2025 Jun 17:S0012-3692(25)00700-7. doi: 10.1016/j.chest.2025.
    PubMed         Abstract available
    
    
19. HOWINGTON J, Souter LH, Arenberg D, Blasberg J, et al
    Management of Patients with Early-Stage Non-Small Cell Lung Cancer: An American College of Chest Physicians Clinical Practice Guideline.
    Chest. 2025 Jun 23:S0012-3692(25)00737-8. doi: 10.1016/j.chest.2025.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

20. DAVAR D, Eroglu Z, Milhem M, Becerra C, et al
    Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer: AMBER Part 2B.
    Clin Cancer Res. 2025 Jun 24:OF1-OF9. doi: 10.1158/1078-0432.CCR-25-0806.
    PubMed         Abstract available
    
    
21. GAY CM, Owonikoko TK, Byers LA, Choudhury NJ, et al
    Multidimensional Analysis of B7 homolog 3 (B7-H3) RNA Expression in Small-cell Lung Cancer Molecular Subtypes.
    Clin Cancer Res. 2025 Jun 24. doi: 10.1158/1078-0432.CCR-24-3981.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

22. LIN JX, Zhou Q, Yan HH, Liu AW, et al
    A Patient-Centric, Open-Label, Multicenter, Phase II Study of Lorlatinib Monotherapy in the First-Line Treatment of Patients With locally Advanced or Metastatic ALK-Positive Non-Small Cell Lung Cancer (CTONG2203).
    Clin Lung Cancer. 2025 May 28:S1525-7304(25)00127.
    PubMed         Abstract available
    
    
23. KOSTER KL, Yohasenan S, Pakmak AS, Mark M, et al
    Predictors of Multidisciplinary Tumor Board Adherence in Stage III Non-Small-Cell Lung Cancer Patients From a Large Multicenter Study.
    Clin Lung Cancer. 2025 May 29:S1525-7304(25)00124.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

24. O'REILLY D, O'Grady A, Hayes C, Piggott L, et al
    Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN study.
    Eur J Cancer. 2025;225:115582.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

25. ZHANG SC, Kehayias CE, Guthier C, He J, et al
    Differential Impact of Left Ventricular Myocardium and Left Coronary Radiation Dose with Incident Heart Failure and Coronary Events in Lung Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2025 Jun 25:S0360-3016(25)04493.
    PubMed         Abstract available
    
    
26. SAMSON P, Robinson C
    How to Avoid Collapsing Under the Pressure of Managing Atelectasis During Lung Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:785.
    PubMed        
    
    
27. MEYER S, Hu YC, Rimner A, Mechalakos J, et al
    Deformable Image Registration Uncertainty-Encompassing Dose Accumulation for Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:818-826.
    PubMed         Abstract available
    
    
28. CHUONG MD, Mittauer KE, Bassetti MF, Rojas C, et al
    Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy in One Fraction (SMART ONE): A Multicenter, Single-Arm, Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2025;122:957-967.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

29. STEUER CE, Hayashi H, Su WC, Nishio M, et al
    Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy.
    J Clin Oncol. 2025 Jun 24:JCO2402744. doi: 10.1200/JCO-24-02744.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

30. ZERVOS M, Park BJ, Marshall MB, Wee JO, et al
    Robotic-assisted single-port system for pulmonary lobectomy: A prospective feasibility study.
    J Thorac Cardiovasc Surg. 2025;170:54-60.
    PubMed         Abstract available
    
    

    
    JAMA Oncol

31. LI H, Chen K, Gong L, Qin J, et al
    High-Dose Aumolertinib for Untreated EGFR-Variant Non-Small Cell Lung Cancer With Brain Metastases: The ACHIEVE Phase 2 Nonrandomized Clinical Trial.
    JAMA Oncol. 2025 Jun 26. doi: 10.1001/jamaoncol.2025.1779.
    PubMed         Abstract available
    
    
32. MARKS JA, Liu SV
    Navigating Selective Dose Intensification in EGFR-Variant Non-Small Cell Lung Cancer.
    JAMA Oncol. 2025 Jun 26. doi: 10.1001/jamaoncol.2025.1768.
    PubMed        
    
    

    
    Lung Cancer

33. GEORGE JE, George PS, Krishna JKM, Mathew A, et al
    Global trends in lung cancer incidence and mortality by age, gender and morphology and forecast: A bootstrap-based analysis.
    Lung Cancer. 2025;205:108626.
    PubMed         Abstract available
    
    
34. WU Y, Xie Y, Chen Y, Li J, et al
    Bronchial washing fluid supernatant serves as a novel liquid biopsy specimen for genome profiling in advanced non-small cell lung cancer.
    Lung Cancer. 2025;205:108622.
    PubMed         Abstract available
    
    
35. PEREZ-PEREZ M, de Sola-Llamas CG, Macias-Garcia L
    Diagnostic accuracy of the Idylla mutation test for detecting EGFR mutations in non-small cell lung cancer: a meta-analysis.
    Lung Cancer. 2025;205:108623.
    PubMed         Abstract available
    
    
36. ZHANG M, Tang Y, Liang J, Zhu L, et al
    Combination of anlotinib and irinotecan as second-line therapy in extensive-stage small-cell lung cancer relapsed within six months: a single-arm phase ? study.
    Lung Cancer. 2025;205:108630.
    PubMed         Abstract available
    
    
37. GAWLI CS, Patil BR, Nagpure NR, Patil CR, et al
    Prevalence of osimertinib-induced cardiotoxicity in non-small cell lung cancer patients: a systematic review and meta-analysis.
    Lung Cancer. 2025;205:108629.
    PubMed         Abstract available
    
    
38. MOGHANAKI D, Cameron EA, Garon EB
    Unbridled Enthusiasm for Neoadjuvant Chemoimmunotherapy followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer.
    Lung Cancer. 2025 Jun 20:108628. doi: 10.1016/j.lungcan.2025.108628.
    PubMed        
    
    
39. SUNG H, Jiang C, Schafer EJ, Bandi P, et al
    Burden and trends in subsequent primary lung cancer incidence by sex in the United States.
    Lung Cancer. 2025;205:108625.
    PubMed         Abstract available
    
    

    
    Mol Carcinog

40. GONG Z, Yu F, Li C, Zhao B, et al
    Four-gene Prognostic Signature and Risk of Brain Metastasis of Lung Adenocarcinoma.
    Mol Carcinog. 2025;64:1209-1221.
    PubMed         Abstract available
    
    
41. LIU Z, Lenz HJ, Yu J, Zhang L, et al
    Differential Response and Resistance to KRAS-Targeted Therapy.
    Mol Carcinog. 2025;64:1135-1148.
    PubMed         Abstract available
    
    

    
    Oncologist

42. ISAWA T, Togashi S, Taguri M, Toi Y, et al
    Cardiovascular adverse events in patients with lung cancer treated with immune checkpoint inhibitors: a nationwide database study.
    Oncologist. 2025;30:oyaf151.
    PubMed         Abstract available
    
    
43. WANG W, Xu X, Liu H, Cui Y, et al
    The prognostic value of sarcopenia and sarcopenic obesity in patients with lung cancer receiving immunotherapy: a propensity score matching study.
    Oncologist. 2025;30:oyaf114.
    PubMed         Abstract available
    
    
44. LI G, Greene SB, Kaur B, Keller-Evans RB, et al
    Clinical utility of companion diagnostic biomarker results below the limit of detection in comprehensive genomic profiling of patients with advanced non-small cell lung cancer.
    Oncologist. 2025;30:oyaf159.
    PubMed         Abstract available
    
    

    
    PLoS One

45. PUTHDEE N, Mai VH, Settayanon S, Chanvorachote P, et al
    HMGB1-BoxA gene therapy in reversing cisplatin resistance in non-small cell lung cancer.
    PLoS One. 2025;20:e0327144.
    PubMed         Abstract available
    
    
46. RENIERS T, Noordzij PG, Veen EJ, Hofman EFN, et al
    Does postoperative plasma IL-6 improve early prediction of infection after pulmonary cancer surgery? A two-centre prospective study.
    PLoS One. 2025;20:e0326537.
    PubMed         Abstract available
    
    

    
    Thorax

47. ROCHE JJ, Seyedshahi F, Rakovic K, Thu AW, et al
    Current and future applications of artificial intelligence in lung cancer and mesothelioma.
    Thorax. 2025 Jun 20:thorax-2024-222054. doi: 10.1136/thorax-2024-222054.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.